Patent ID: 11957783
Assignee: SQUAREX PHARMACEUTICAL CORPORATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of treating a fungal infection comprising:
applying a topical immunosensitizer to the skin or a mucous membrane of a person infected with a fungus and in recognized need of treatment for the fungal infection;
wherein the applying step is done no more than 6 times in a 12 month period;
wherein the topical immunosensitizer is squaric acid dibutyl ester (SADBE), a squaric acid ester, diphenylcyclopropenone (DPCP), 1-chloro-2,4-dinitrobenzene (DNCB), 1-chloro-2,6-dinitrobenzene, or urushiol;
wherein if the fungal infection is an infection of the skin or mucous membrane the method does not comprise applying the topical immunosensitizer to at least some area or areas of diseased skin or diseased mucous membrane of the person arising from the fungal infection; and
wherein the person is in recognized need of treatment for the fungal infection.